Abivax (ABVX) Retained Earnings (2021 - 2026)
Abivax (ABVX) posted quarterly Retained Earnings of -$838.1 million for Q1 2026, down 83.52% year-over-year from -$5.1 billion in Q1 2025, and down 78.93% quarter-over-quarter from -$468.4 million in Q4 2025.
Abivax (ABVX) Retained Earnings (2021 - 2026) Analysis & Trends
Abivax's Retained Earnings history runs 6 years deep, the most recent figure standing at -$838.1 million for Q1 2026.
- In Q1 2026, Retained Earnings fell 83.52% year-over-year to -$838.1 million; the TTM figure through Mar 2026 stood at -$838.1 million (down 83.52% YoY), while the FY2025 annual figure was -$468.4 million, down 66.89% from the prior year.
- Retained Earnings for Q1 2026 stood at -$838.1 million, down from -$468.4 million in the prior quarter.
- The five-year high for Retained Earnings was -$84.4 million in Q4 2022, with the low at -$838.1 million in Q1 2026.
- The 5-year median for Retained Earnings is -$456.7 million (2025), against an average of -$392.9 million.
- The sharpest annual moves came in 2024 and 2025: Retained Earnings sank 92.92% in 2024, then tumbled 65.66% in 2025.
- Abivax's Retained Earnings stood at -$84.4 million in 2022, then sank by 72.27% to -$145.5 million in 2023, then tumbled by 92.92% to -$280.7 million in 2024, then sank by 66.89% to -$468.4 million in 2025, then sank by 78.93% to -$838.1 million in 2026.
- Business Quant data shows ABVX's Retained Earnings at -$838.1 million in Q1 2026, -$468.4 million in Q4 2025, and -$485.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Abivax | 9.39 Bn | 9.39 Bn | - | -838.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -838.07 Mn |
| Dec 31, 2025 | -468.39 Mn |
| Sep 30, 2025 | -485.94 Mn |
| Jun 30, 2025 | -484.27 Mn |
| Mar 31, 2025 | -456.67 Mn |
| Dec 31, 2024 | -280.65 Mn |
| Jun 30, 2024 | -292.34 Mn |
| Dec 31, 2023 | -145.48 Mn |
| Dec 31, 2022 | -84.45 Mn |
| Dec 31, 2021 | -45.03 Mn |